Tribulus Terrestris Supplement Manufacturer

Tribulus extracts are often hygroscopic, bitter, and hard to keep uniform from sample to commercial fill. The technologies below map common commercial failure points to KS process controls – not a second format-selection menu.

Request Technology Feasibility Review · Request Advanced Capsule Feasibility

Three decisions are enough to start a workable manufacturing brief.

Question 1: What product category are you developing?

Men’s wellness · Sports nutrition · Botanical supplement · Premium documentation-led SKU

Question 2: What dosage form are you manufacturing?

Capsules · Tablets · Powders / sticks · Gummies

Question 3: What analytical specification do you require?

Total saponins (UV-Vis) · HPLC marker (e.g., protodioscin) · Custom specification

Note: UV total saponins and HPLC protodioscin are different analytical stories and are not interchangeable on price alone. Higher assay % is not automatically better for every format.

Request Spec Recommendation

Sample-to-commercial drift is the main Tribulus OEM risk. This section covers how KS locks transfer from approved sample to released bulk, then keeps supply and reorders under the same controls.

A. Consistency controls (sample to commercial release)

Before production

Pilot failures trigger re-pilot – not silent scale-up. Spec or solvent changes require a formal change notice.

During production

Before shipment – release panel

COAs report numerical results against the locked specification revision. Two retain samples per lot are held for shelf life + additional retain period.

Sample-to-bulk rules

1. Commercial lots use the same master specification as the approved sample unless both parties sign an amendment.
2. Every commercial lot is released independently – a sample COA is not reused as a permanent pass.
3. Multi-lot assay trends are reviewed; drift toward the lower control limit triggers raw-material review before the next reorder.
4. Clients may request retain re-test or side-by-side comparison against the approved reference sample as scoped.

Analytical capability: In-house HPLC · UV-Vis · GC · ICP-MS · Third-party ISO 17025 labs as scoped
Systems: cGMP · ISO 9001 · ISO 22000 · HACCP · FSSC 22000 · Halal · Kosher · Non-GMO pathways

B. Supply reliability (what stays after consistency is locked)

Dual-path sourcing

• Primary Tribulus grade is locked on the BOM (plant part + marker + method + acceptance range).
• For active private label / OEM programs, a second qualified source or alternate lot pathway can be pre-approved.
• Any source change requires identity / assay re-qualification. Silent substitutions are not permitted.

Lot traceability

U.S. staging & reorder continuity

• Approved commercial BOMs are frozen for reorder.
• U.S.-bound programs can stage finished goods through Los Angeles and New Jersey warehouse support for qualified North America shipments.
• Reorder POs reference the prior commercial lot / BOM revision.

What we will not do to “keep supply moving”

• Switch plant part or assay method without written customer approval
• Use a higher UV % quote as a substitute for an HPLC protodioscin lock
• Ship against an incomplete COA pack when release testing is still open

→ Quality Control · Certifications · Manufacturing Capacity

Request COA Example Pack · Request Supply & Traceability Brief

We do not claim zero risk. Responsible manufacturing requires a structured approach to identify, investigate, and resolve quality concerns while protecting brand reputation.

1. Intake & Assessment

Document:

• Batch / lot information
• Complaint scope
• Available evidence
• Product conditions

Purpose: Establish a clear understanding of the reported concern.

2. Containment

Where applicable:

• Review affected inventory
• Evaluate shipment status
• Define temporary control actions

Purpose: Prevent potential issues from expanding while investigation is ongoing.

3. Investigation

Review available records, including:

• COA and quality documents
• Retention sample testing (when applicable)
• Production and process records

Purpose: Identify whether the issue is related to material, process, packaging, or handling factors.

4. Root Cause Analysis

Evaluate potential sources:

• Raw material variation
• Manufacturing parameters
• Packaging conditions
• Storage or transportation factors

5. Corrective & Preventive Actions (CAPA)

Actions may include:

• Process improvement
• Additional verification testing
• Specification review
• Preventive measures for future batches

6. Close-Out & Continuous Improvement

Provide:

• Investigation conclusion
• Resolution documentation
• Prevention recommendations for future production

Commercial shipments can be supplied with the documentation packs commonly required for quality release, import clearance, and customer audits.

Brand owners remain responsible for finished-label claims and market-entry legality. KS provides manufacturing feasibility and documentation support – not legal approval.

→ Certifications · Quality Control

Request Document Pack Checklist

Collaboration workflow

1. Brief intake
   Private label / ODM / OEM formula / bulk extract scope
        ↓
2. Spec & BOM lock
   Plant part · marker + method · format · pack configuration
        ↓
3. Sample / pilot approval
   Evaluation sample or pilot batch against locked criteria
        ↓
4. Artwork & documentation alignment
   Label components and COA / TDS revision matched to the same BOM
        ↓
5. Commercial production & release
   In-process controls · finished testing · retain samples
        ↓
6. Shipment & reorder
   Export pack handover · next PO against the frozen BOM

Typical lead-time windows

Final lead times are confirmed after formula review, packaging selection, and order confirmation. Shelf-life planning is typically 24 months in original sealed packaging (project-scoped).

Request Project Timeline · Start Collaboration Brief